Skip to main content
. 2016 May 24;6:26645. doi: 10.1038/srep26645

Figure 4. MSCs stably express defining surface markers after bleomycin treatment.

Figure 4

(a) Representative FACS analyses of defining positive MSC markers CD73, CD90 and CD105 and negative markers CD14, CD20, CD34 and CD45 at 24 and 48 hours after treatment with 1800 ng/mL bleomycin. (b) Representative microscopic images of unstained MSCs and adult fibroblasts showing no measurable changes in morphology after treatment with 400 or 1800 ng/mL bleomycin (20× objective, scale bar 100 μm).